rs74799832
|
|
Pheochromocytoma
|
C |
0.740 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Short stature
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Tetralogy of Fallot
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Gingival Overgrowth
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Hypothyroidism
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Range of joint movement increased
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Orbital separation excessive
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
THYROID CARCINOMA, SPORADIC MEDULLARY
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Thick vermilion border
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Constipation
|
C |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
CausalMutation
|
CLINVAR |
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
|
7906866 |
1994 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
CausalMutation
|
CLINVAR |
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
|
7906417 |
1994 |
rs74799832
|
|
Multiple endocrine neoplasia Type 2
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
|
7906417 |
1994 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
CausalMutation
|
CLINVAR |
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
|
7824936 |
1995 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
GeneticVariation
|
CLINVAR |
RET activation by germline MEN2A and MEN2B mutations.
|
8570194 |
1995 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2a
|
C |
0.720 |
GeneticVariation
|
CLINVAR |
RET activation by germline MEN2A and MEN2B mutations.
|
8570194 |
1995 |
rs74799832
|
|
Multiple Endocrine Neoplasia, Type IV
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
RET activation by germline MEN2A and MEN2B mutations.
|
8570194 |
1995 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 1
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
RET activation by germline MEN2A and MEN2B mutations.
|
8570194 |
1995 |
rs74799832
|
|
Multiple endocrine neoplasia Type 2
|
C |
0.700 |
CausalMutation
|
CLINVAR |
RET activation by germline MEN2A and MEN2B mutations.
|
8570194 |
1995 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
CausalMutation
|
CLINVAR |
Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome).
|
8880581 |
1996 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2a
|
C |
0.720 |
CausalMutation
|
CLINVAR |
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
|
8918855 |
1996 |
rs74799832
|
|
Multiple endocrine neoplasia Type 2
|
C |
0.700 |
CausalMutation
|
CLINVAR |
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
|
8918855 |
1996 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2b
|
C |
0.900 |
CausalMutation
|
CLINVAR |
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
|
9242375 |
1997 |
rs74799832
|
|
Multiple Endocrine Neoplasia Type 2a
|
C |
0.720 |
CausalMutation
|
CLINVAR |
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
|
9242375 |
1997 |
rs74799832
|
|
Multiple endocrine neoplasia Type 2
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
|
9242375 |
1997 |